Why is Palantir Technologies stock sliding today?

Palantir shares fell 6.0% in premarket trading to $167.66 despite Q3 2026 revenue of $2.31 billion, up 96% year over year and above the roughly $2.18 billion consensus, and adjusted EPS of $0.44 versus $0.41 expected. Investors focused on total contract value growth slowing to 6% from 49% in Q2 and U.S. commercial TCV growth decelerating to 11% from 153%; analysts cited concerns about the pipeline and valuation. Morgan Stanley raised its price target to $233 but maintained Equalweight, while another analyst downgraded the stock to Hold; insiders had sold more than $97 million of shares over the prior 90 days.

Analysis

The key issue is whether current growth is being sustained by a durable deal engine or by converting prior wins into revenue. If new bookings have genuinely cooled, revenue can remain strong for several quarters while the market begins discounting a weaker 2027 growth slope; at a premium multiple, that duration risk can matter more than another near-term earnings beat. But contract value is lumpy, and one quarter is not enough to distinguish a pipeline break from timing or unusually large prior-period deals. Insider sales add little signal without context on scheduled plans and total ownership. Over the next few days, expect price discovery around whether buyers treat the bookings data as a one-off; over 1–3 months, the next bookings and commercial-growth disclosures are the sharper test. Over 6–18 months, sustained adoption and renewals could support the growth premium, while slowing deal formation would expose multiple-compression risk. A rebound in bookings or upward guidance revisions would falsify the bearish read; continued weakness alongside decelerating revenue would strengthen it.

Key Decisions for Investors

• Avoid chasing the initial gap lower. For a bearish expression, consider a small, defined-risk PLTR put spread after the open once volatility and spreads settle; size for the possibility that the bookings decline proves temporary and the stock rebounds on continued revenue strength.
• For a relative-value expression, consider underweighting PLTR against a diversified software benchmark such as IGV rather than taking an unhedged short. This reduces broad software-sector exposure but does not remove the risk that PLTR outperforms on renewed AI enthusiasm.
• Use the next 1–3 months of disclosures as the decision point: monitor contract value trends, U.S. commercial deal momentum, revenue guidance, and whether management explains the divergence with timing or pipeline evidence. Do not add to a short solely on insider sales or a single quarter’s bookings.
• Falsification trigger: sustained improvement in new-deal metrics accompanied by maintained or raised forward guidance. Confirmation trigger: another period of weak bookings plus a downward revision to growth expectations; reassess then rather than relying on valuation alone.